Clinical features and course of brain metastases in triple-negative breast cancer: Comparison with HER2+ and other type.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Oncology

• Publication date

  2009-05-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2009.27.15_SUPPL.1064PMID 27961168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1

  2017cites this paper
• Evidence for the role of bevacizumab in the treatment of advanced metastatic breast cancer: a review.

  2010cites this paper
• evidence for the role of bevacizumab in the treatment of advanced metastatic breast cancer: a review

  2010cites this paper
• evidence for the role of bevacizumab in the treatment of advanced metastatic breast cancer: a review

  2010cites this paper